Pamela Vig, Head of Research & Development at Mirum Pharmaceuticals, Inc. (MIRM), sold 1,425 shares at $25.65 ($37K) on 2023-07-03, disclosed to the SEC on 2023-07-05.
Open-market sale of $37k MIRM by Head of Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MIRM | SELL | 2024-02-05 | $32K | — | Filing → |
| MIRM | SELL | 2024-01-09 | $39K | — | Filing → |
| MIRM | SELL | 2021-10-01 | $26K | — | Filing → |